See more : Electricité de France S.A. (EDF.PA) Income Statement Analysis – Financial Results
Complete financial analysis of ResMed Inc. (RMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ResMed Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- CMS Energy Corporation (CMS-PC) Income Statement Analysis – Financial Results
- Taihe Group, Inc. (TIHE) Income Statement Analysis – Financial Results
- Willcox International Holdings Inc (WINH) Income Statement Analysis – Financial Results
- American Riviera Bancorp (ARBV) Income Statement Analysis – Financial Results
- Western Mining Co.,Ltd. (601168.SS) Income Statement Analysis – Financial Results
ResMed Inc. (RMD)
About ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.69B | 4.22B | 3.58B | 3.20B | 2.96B | 2.61B | 2.34B | 2.07B | 1.84B | 1.68B | 1.55B | 1.51B | 1.37B | 1.24B | 1.09B | 920.74M | 835.40M | 716.33M | 607.00M | 425.51M | 339.34M | 273.57M | 204.08M | 155.16M | 115.62M | 88.60M | 66.50M | 49.20M | 34.60M | 23.50M | 13.90M | 7.70M |
| Cost of Revenue | 2.03B | 1.87B | 1.55B | 1.36B | 1.24B | 1.07B | 978.03M | 864.99M | 772.22M | 667.52M | 565.19M | 573.80M | 547.78M | 501.82M | 436.87M | 366.93M | 341.65M | 331.84M | 230.10M | 150.65M | 122.60M | 100.48M | 70.83M | 50.38M | 30.74M | 24.80M | 19.40M | 17.70M | 15.70M | 10.70M | 5.90M | 2.90M |
| Gross Profit | 2.66B | 2.36B | 2.02B | 1.84B | 1.72B | 1.54B | 1.36B | 1.20B | 1.07B | 1.01B | 989.79M | 940.66M | 820.74M | 741.33M | 655.48M | 553.80M | 493.75M | 384.49M | 376.90M | 274.86M | 216.74M | 173.09M | 133.25M | 104.78M | 84.87M | 63.80M | 47.10M | 31.50M | 18.90M | 12.80M | 8.00M | 4.80M |
| Gross Profit Ratio | 56.67% | 55.78% | 56.57% | 57.53% | 58.09% | 58.95% | 58.21% | 58.15% | 58.00% | 60.24% | 63.65% | 62.11% | 59.97% | 59.63% | 60.01% | 60.15% | 59.10% | 53.68% | 62.09% | 64.60% | 63.87% | 63.27% | 65.29% | 67.53% | 73.41% | 72.01% | 70.83% | 64.02% | 54.62% | 54.47% | 57.55% | 62.34% |
| Research & Development | 307.53M | 287.64M | 253.58M | 225.28M | 201.95M | 180.65M | 155.15M | 144.47M | 118.65M | 114.87M | 118.23M | 120.12M | 109.73M | 92.01M | 75.20M | 63.06M | 60.52M | 50.11M | 37.22M | 30.01M | 26.17M | 20.53M | 14.91M | 11.15M | 8.50M | 6.50M | 5.00M | 3.80M | 2.80M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 600.37M | 553.97M | 488.06M | 478.63M | 450.41M | 430.80M | 401.62M | 372.25M | 331.86M | 289.88M | 278.09M | 237.33M | 200.17M | 135.70M | 104.71M | 85.31M | 64.48M | 49.91M | 36.99M | 27.40M | 21.10M | 16.80M | 11.10M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -5.46M | -6.00M | 0.00 | 0.00 | 0.00 | -1.00M | -3.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 917.14M | 874.00M | 739.37M | 670.39M | 676.69M | 645.01M | 600.37M | 553.97M | 482.59M | 472.63M | 450.41M | 430.80M | 401.62M | 371.25M | 328.86M | 289.88M | 278.09M | 237.33M | 200.17M | 135.70M | 104.71M | 85.31M | 64.48M | 49.91M | 36.99M | 27.40M | 21.10M | 16.80M | 11.10M | 9.40M | 6.40M | 3.90M |
| Other Expenses | 110.75M | -5.71M | 31.08M | 31.08M | 30.09M | 74.94M | -8.54M | 4.10M | 4.96M | 6.25M | 884.00K | -2.19M | 8.46M | 10.15M | 8.04M | 7.06M | 9.79M | 6.90M | 7.09M | 1.37M | 500.00K | 0.00 | 104.67M | 0.00 | 6.25M | 4.60M | 3.70M | 2.60M | 1.30M | 600.00K | 300.00K | 200.00K |
| Operating Expenses | 1.34B | 1.20B | 1.02B | 926.75M | 908.73M | 900.60M | 801.90M | 745.01M | 625.17M | 596.16M | 578.37M | 585.83M | 525.33M | 473.40M | 412.10M | 359.99M | 348.40M | 294.33M | 244.47M | 167.09M | 131.38M | 105.85M | 184.06M | 61.06M | 51.73M | 38.50M | 29.80M | 23.20M | 15.20M | 10.00M | 6.70M | 4.10M |
| Cost & Expenses | 3.37B | 3.07B | 2.58B | 2.28B | 2.15B | 1.97B | 1.78B | 1.61B | 1.40B | 1.26B | 1.14B | 1.16B | 1.07B | 975.22M | 848.98M | 726.92M | 690.05M | 626.17M | 474.57M | 317.73M | 253.98M | 206.33M | 254.89M | 111.44M | 82.48M | 63.30M | 49.20M | 40.90M | 30.90M | 20.70M | 12.60M | 7.00M |
| Interest Income | 0.00 | 47.38M | 22.31M | 362.00K | 1.02M | 2.30M | 16.38M | 17.09M | 16.86M | 26.21M | 31.24M | 38.87M | 33.87M | 27.80M | 16.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 45.71M | 47.38M | 22.31M | 23.99M | 40.38M | 36.16M | 28.36M | 28.24M | 11.21M | 5.78M | 6.13M | 6.39M | 4.79M | 1.76M | 10.06M | 10.06M | 10.06M | 1.32M | 1.32M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 216.21M | 196.52M | 193.84M | 191.52M | 181.37M | 150.80M | 119.96M | 112.16M | 86.85M | 73.06M | 9.73M | 10.14M | 13.97M | 10.15M | 8.04M | 7.06M | 59.49M | 48.14M | 41.62M | 29.13M | 17.87M | 12.58M | 9.97M | 8.45M | 6.25M | 4.60M | 3.70M | 2.60M | 1.30M | 600.00K | 300.00K | 200.00K |
| EBITDA | 1.53B | 1.36B | 1.18B | 1.10B | 990.43M | 705.80M | 680.22M | 568.89M | 522.72M | 482.29M | 484.87M | 469.79M | 422.59M | 374.32M | 322.15M | 190.31M | 204.83M | 90.16M | 174.04M | 136.90M | 85.36M | 79.82M | -40.84M | 52.16M | 39.39M | 29.90M | 21.00M | 10.90M | 4.90M | 3.40M | 1.60M | 900.00K |
| EBITDA Ratio | 32.73% | 31.72% | 33.37% | 34.80% | 33.47% | 32.36% | 29.85% | 29.02% | 29.40% | 29.44% | 27.49% | 24.10% | 22.68% | 23.31% | 22.73% | 22.07% | 24.47% | 19.12% | 28.86% | 34.72% | 30.28% | 28.29% | -21.95% | 43.70% | 33.87% | 35.44% | 33.53% | 16.46% | 5.78% | 10.21% | 7.91% | 3.90% |
| Operating Income | 1.32B | 1.13B | 1.00B | 903.68M | 809.66M | 579.26M | 541.83M | 425.80M | 428.95M | 409.24M | 405.09M | 354.82M | 294.41M | 266.92M | 240.38M | 190.31M | 142.97M | 90.16M | 131.30M | 97.35M | 85.36M | 67.24M | -51.16M | 26.04M | 33.14M | 25.30M | 17.30M | 8.30M | 3.70M | 2.80M | 1.30M | 700.00K |
| Operating Income Ratio | 28.17% | 26.80% | 27.96% | 28.27% | 27.38% | 22.22% | 23.15% | 20.60% | 23.33% | 24.38% | 26.05% | 23.43% | 21.51% | 21.47% | 22.01% | 20.67% | 17.11% | 12.59% | 21.63% | 22.88% | 25.16% | 24.58% | -25.07% | 16.78% | 28.66% | 28.56% | 26.02% | 16.87% | 10.69% | 11.91% | 9.35% | 9.09% |
| Total Other Income/Expenses | -55.10M | -30.21M | -39.80M | -20.02M | -76.57M | -60.42M | -20.52M | -7.06M | 10.61M | 26.68M | 25.99M | 30.30M | 37.54M | 36.78M | 20.21M | 11.37M | 14.89M | 7.81M | 2.09M | -727.00K | -693.00K | -113.00K | 105.75M | 1.27M | 1.03M | -700.00K | -1.20M | 2.80M | 2.90M | 900.00K | 500.00K | 500.00K |
| Income Before Tax | 1.26B | 1.10B | 960.48M | 883.66M | 733.09M | 518.85M | 521.31M | 418.74M | 439.57M | 435.92M | 431.08M | 385.12M | 331.95M | 303.71M | 260.59M | 201.68M | 157.86M | 97.97M | 133.39M | 96.63M | 84.67M | 67.13M | 54.59M | 27.31M | 34.17M | 24.60M | 16.10M | 11.10M | 6.60M | 3.70M | 1.80M | 1.20M |
| Income Before Tax Ratio | 27.00% | 26.09% | 26.84% | 27.64% | 24.79% | 19.91% | 22.28% | 20.26% | 23.91% | 25.96% | 27.72% | 25.43% | 24.26% | 24.43% | 23.86% | 21.90% | 18.90% | 13.68% | 21.98% | 22.71% | 24.95% | 24.54% | 26.75% | 17.60% | 29.55% | 27.77% | 24.21% | 22.56% | 19.08% | 15.74% | 12.95% | 15.58% |
| Income Tax Expense | 243.85M | 204.11M | 181.05M | 409.16M | 111.41M | 114.26M | 205.72M | 76.46M | 87.16M | 83.03M | 85.81M | 77.99M | 77.10M | 76.72M | 70.50M | 55.24M | 47.55M | 31.67M | 45.18M | 31.84M | 27.38M | 21.40M | 17.09M | 15.68M | 11.94M | 8.50M | 5.50M | 3.60M | 2.10M | 900.00K | 600.00K | 400.00K |
| Net Income | 1.02B | 897.56M | 779.44M | 474.51M | 621.67M | 404.59M | 315.59M | 342.28M | 352.41M | 352.89M | 345.27M | 307.13M | 254.85M | 226.99M | 190.09M | 146.45M | 110.30M | 66.30M | 88.21M | 64.79M | 57.28M | 45.73M | 37.51M | 11.63M | 22.23M | 16.10M | 10.60M | 7.50M | 4.50M | 2.80M | 1.20M | 800.00K |
| Net Income Ratio | 21.79% | 21.25% | 21.78% | 14.84% | 21.02% | 15.52% | 13.49% | 16.56% | 19.17% | 21.02% | 22.20% | 20.28% | 18.62% | 18.26% | 17.40% | 15.91% | 13.20% | 9.26% | 14.53% | 15.23% | 16.88% | 16.72% | 18.38% | 7.50% | 19.22% | 18.17% | 15.94% | 15.24% | 13.01% | 11.91% | 8.63% | 10.39% |
| EPS | 6.94 | 6.12 | 5.34 | 3.27 | 4.31 | 2.83 | 2.21 | 2.42 | 2.51 | 2.51 | 2.44 | 2.15 | 1.75 | 1.49 | 1.26 | 0.97 | 0.72 | 0.43 | 0.61 | 0.47 | 0.43 | 0.35 | 0.29 | 0.09 | 0.19 | 0.14 | 0.09 | 0.06 | 0.04 | 0.04 | 0.02 | 0.02 |
| EPS Diluted | 6.92 | 6.09 | 5.30 | 3.24 | 4.27 | 2.80 | 2.19 | 2.40 | 2.49 | 2.47 | 2.39 | 2.10 | 1.71 | 1.44 | 1.23 | 0.95 | 0.70 | 0.43 | 0.58 | 0.46 | 0.41 | 0.33 | 0.28 | 0.09 | 0.17 | 0.13 | 0.09 | 0.06 | 0.04 | 0.04 | 0.02 | 0.02 |
| Weighted Avg Shares Out | 147.02M | 146.77M | 146.07M | 145.31M | 144.34M | 143.11M | 142.76M | 141.36M | 140.24M | 140.47M | 141.47M | 142.95M | 145.90M | 152.47M | 150.91M | 151.26M | 154.76M | 153.42M | 144.61M | 137.29M | 134.78M | 132.22M | 128.70M | 124.52M | 120.61M | 117.66M | 116.16M | 117.07M | 112.50M | 70.00M | 53.33M | 48.00M |
| Weighted Avg Shares Out (Dil) | 147.55M | 147.46M | 147.04M | 146.45M | 145.65M | 144.48M | 143.99M | 142.45M | 141.67M | 142.69M | 144.36M | 146.41M | 149.32M | 157.20M | 155.10M | 154.23M | 157.42M | 156.51M | 154.32M | 149.88M | 140.50M | 137.76M | 136.32M | 133.94M | 129.21M | 124.27M | 120.28M | 117.07M | 112.50M | 70.00M | 53.33M | 48.00M |
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
ResMed (RMD) is an Incredible Growth Stock: 3 Reasons Why
Is ResMed Stock a Smart Addition to Your Portfolio Right Now?
ResMed (RMD) Earnings Expected to Grow: Should You Buy?
PHG or RMD: Which Is the Better Value Stock Right Now?
5 Dividend Growth Stocks to Buy in Q4
ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
My Top 15 High Growth Dividend Stocks For October 2024
ResMed (RMD) Upgraded to Buy: What Does It Mean for the Stock?
Scoop up These 4 GARP Stocks to Receive Handsome Returns
Source: https://incomestatements.info
Category: Stock Reports